ArticleInflammopharmacology2024

Liensinine reduces acute lung injury brought on by lipopolysaccharide by inhibiting the activation of the NF-κB signaling pathway through modification of the Src/TRAF6/TAK1 axis.

Huizhen Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.